en.Wedoany.com Reported - Global agricultural company Syngenta Group recently announced its full-year and fourth-quarter 2025 financial results. The overall performance demonstrates the company's operational resilience, profitability, and cash flow stability in a complex environment.
Syngenta Group's full-year 2025 sales were $28.4 billion. After adjusting for a $1 billion strategic reduction in low-margin grain trade, underlying growth was 2%, although reported sales decreased by 1% year-on-year. The performance growth was primarily driven by increased sales volumes of crop protection products, attributable to continuous product innovation. Full-year EBITDA reached $4.4 billion, a 13% increase year-on-year, with the EBITDA margin expanding by 1.9 percentage points to 15.4%. Fourth-quarter sales were $7.6 billion, up 2% year-on-year, with growth in Crop Protection and Seeds offsetting declines at ADAMA and SGC. However, EBITDA decreased by 16% year-on-year, mainly impacted by MAP restructuring, increased customer credit provisions in Brazil, and a high comparison base in the same period last year.
Facing challenges such as global uncertainty, low commodity prices, and trade disruptions, Syngenta Group drove performance by launching new products across its business units. The company also prioritized artificial intelligence, achieving measurable financial impact through its "Lighthouse" projects. Syngenta stated: "This disciplined approach has already delivered measurable financial impact and built a scalable blueprint that will accelerate the company's overall transformation." The Group's Biologicals business achieved double-digit sales growth, benefiting from the new production facility in Orangeburg, South Carolina, which complements existing sites in Brazil, Italy, India, and Norway.
In personnel matters, Syngenta appointed Jiang Ning as Group Chief Financial Officer, effective March 1, 2026. Jiang Ning brings over 30 years of financial leadership experience and will relocate to Basel. Jeff Keuntje transitions to the role of Chief Operating Officer, responsible for strategy execution and corporate functions.
In specific business segments, full-year Crop Protection sales reached $13.7 billion, a 4% increase (3% at constant exchange rates). North America led regional growth with a 10% increase, China grew by 8%, while Brazil and Latin America faced price pressure and currency effects. Total Seed sales were $4.8 billion, up 2%, with strong performance in Brazil and Latin America, while North America declined by 12% due to restructuring. Syngenta Group secured over 1,800 approvals globally, including U.S. EPA approval for PLINAZOLIN® technology, registration of TYMIRIUM® in multiple markets, and the launch of ALTESSIA® in India. The company also expanded its global infrastructure, opening an advanced seed health lab in the Netherlands and investing in Guatemala to accelerate fruit crop innovation.
Syngenta China's 2025 sales were $8.3 billion, down 10%, primarily due to the strategic reduction in grain trade, although Seed and Branded Formulations grew by 7% and 5%, respectively. Furthermore, the company divested its stake in Sinofert Holdings effective December 31, 2025, removing the fertilizer business from consolidated results. ADAMA's total sales were $4.1 billion, down 2%, but EBITDA and margins improved for the sixth consecutive quarter, with North America growing by 11% and Asia Pacific (excluding China) declining by 16% due to strategic commodity reductions.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
